Clinical Trial Update: Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares insulin aspart (NovoRapid) with regular human insulin (Actrapid) in Type 1 diabetes during daily dose adjustments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Actrapid (insulin human regular)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Odense University Hospital | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: UNKNOWN